{"created":"2023-06-20T15:52:51.010701+00:00","id":7201,"links":{},"metadata":{"_buckets":{"deposit":"7f8744fb-6b45-4ddc-9417-1362d03663ab"},"_deposit":{"created_by":34,"id":"7201","owners":[34],"pid":{"revision_id":0,"type":"depid","value":"7201"},"status":"published"},"_oai":{"id":"oai:redcross.repo.nii.ac.jp:00007201","sets":["195:197:231"]},"author_link":["25807","25808"],"item_10002_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2013-12","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"1","bibliographicPageEnd":"21","bibliographicPageStart":"17","bibliographicVolumeNumber":"38","bibliographic_titles":[{"bibliographic_title":"松山赤十字病院医学雑誌"}]}]},"item_10002_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"ビスフォスフォネート関連顎骨壊死(BRONJ)の頻度は、最近の報告では注射剤で0.2%程度、内服薬で0.05%程度とされている。当科では2007年10月に一例目を経験して以降、2012年3月までに20症例を経験した。今回われわれは、当科で加療もしくは経過観察を行った20症例について臨床的検討を行ったので報告する。症例の平均年齢は73.05歳、男女比は1:3であった。ビスフォスフォネート剤(以下BP剤)を使用していた原疾患は乳癌が7例、前立腺癌2例、多発性骨髄腫2例、骨粗鬆症が9例で、BP剤の投与経路は注射薬が11例、内服薬が9例であった。投与開始から発症までの期間は平均2年5ヵ月で、発症の誘因と考えられた歯科処置は、抜歯と歯周病などからの感染が8例ずつと最も多く、インプラント周囲炎が1例、原因不明が3例であった。治療内容は保存的治療(急性期のみ消炎治療を行い、症状緩解期は経過観察を基本とする)が11例、腐骨除去術や顎骨掻爬術などの外科的治療を行ったものが9例で、治療により治癒した症例は全て外科的治療を行った症例であった。外科的治療の際には全ての症例でBP剤の投与を中止したが、治癒と判断した後にBP剤の投与を再開した症例はなかった。(著者抄録)","subitem_description_type":"Abstract"}]},"item_10002_source_id_11":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{}]},"item_10002_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0385-3888","subitem_source_identifier_type":"ISSN"}]},"item_10002_version_type_20":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"寺門, 永顕"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"兵頭, 正秀"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2015-03-25"}],"displaytype":"simple","filename":"寺門先生(XMF-4C).pdf","filesize":[{"value":"15.6 MB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"matsuyama00003","url":"https://redcross.repo.nii.ac.jp/record/7201/files/寺門先生(XMF-4C).pdf"},"version_id":"b94c396b-b01c-410e-a781-c6119632cbbc"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"Bisphosphonate","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"osteonecrosis","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"BRONJ","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"松山赤十字病院歯科口腔外科におけるビスフォスフォネート関連顎骨壊死症例の臨床的検討","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"松山赤十字病院歯科口腔外科におけるビスフォスフォネート関連顎骨壊死症例の臨床的検討"}]},"item_type_id":"10002","owner":"34","path":["231"],"pubdate":{"attribute_name":"公開日","attribute_value":"2015-03-25"},"publish_date":"2015-03-25","publish_status":"0","recid":"7201","relation_version_is_last":true,"title":["松山赤十字病院歯科口腔外科におけるビスフォスフォネート関連顎骨壊死症例の臨床的検討"],"weko_creator_id":"34","weko_shared_id":-1},"updated":"2023-06-20T20:15:05.585720+00:00"}